Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is of fair value on EV/EBITDA, trading a
Target Price
The average target price of 1951.HK is 3.5 and suggests 46% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell